Company news
Inovio Pharmaceuticals, Inc. news in 2026
Inovio Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.
INOVIO Announces Pricing of Approximately $75 Million Public Offering
November 5, 2026
INOVIO Announces Proposed Public Offering of its Common Stock
November 5, 2026
INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026
November 2, 2026
INOVIO to Participate in Upcoming Scientific Conferences
November 2, 2026
INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)
October 30, 2026
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
October 20, 2026
INOVIO to Participate in Upcoming Investor Conferences
September 1, 2026
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026
INOVIO to Report Second Quarter Financial Results on August 12, 2026
August 4, 2026
INOVIO Announces Pricing of $20.0 Million Public Offering
July 29, 2026
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
May 21, 2026
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 12, 2026
INOVIO to Report First Quarter Financial Results on May 13, 2026
May 1, 2026
INOVIO Announces Pricing of $17.5 Million Public Offering
April 1, 2026
INOVIO to Participate in Upcoming Scientific Conference
April 1, 2026
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 12, 2026
INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
March 4, 2026
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
March 4, 2026
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
March 4, 2026
INOVIO to Participate in Upcoming Scientific and Investor Conferences
February 12, 2026
Calls in 2026
Decks in 2026
- Corporate Update (November 2026)
Corporate update · 25 slides · Nov 2, 2026
- Q2 2026 Earnings Presentation
Earnings · 19 slides · August 2026
- Investor Presentation (June 2026)
Investor deck · 42 slides · June 2026
- Q1 2026 Earnings Presentation
Earnings · 19 slides · May 13, 2026
- Q1 2026 Earnings Presentation
Earnings · 39 slides · May 13, 2026
- World Federation of Hemophilia World Congress 2026
Conference · 13 slides · Apr 22, 2026
- WFH 2026 World Congress
Conference · 5 slides · Apr 22, 2026
- Q4 2025 Earnings Presentation
Earnings · 18 slides · Mar 12, 2026
- Festival of Genomics and Biodata 2026
Conference · 26 slides · Jan 28, 2026